ALEXANDRIA, Va., June 10 -- United States Patent no. 12,292,442, issued on May 6, was assigned to BIOSWAN LABORATORIES INC. (Shanghai).
"Monoclonal antibody against CD19 antibody and application thereof" was invented by Liang Da (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a monoclonal antibody against CD19 antibody and the application thereof. The monoclonal antibody which targets CD 19 antibody has high specificity and strong affinity. Also provided are a detection reagent with high sensitivity, good accuracy and good specificity for the detection of CAR-T cells and a detection method using the detection reagent, which may directly target an extracellular antigen-binding region on ...